94 reports of this reaction
7.0% of all AMINOCAPROIC ACID reports
#1 most reported adverse reaction
HAEMORRHAGE is the #1 most commonly reported adverse reaction for AMINOCAPROIC ACID, manufactured by American Regent, Inc.. There are 94 FDA adverse event reports linking AMINOCAPROIC ACID to HAEMORRHAGE. This represents approximately 7.0% of all 1,338 adverse event reports for this drug.
Patients taking AMINOCAPROIC ACID who experience haemorrhage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAEMORRHAGE is moderately reported among AMINOCAPROIC ACID users, representing a notable but not dominant share of adverse events.
In addition to haemorrhage, the following adverse reactions have been reported for AMINOCAPROIC ACID:
The following drugs have also been linked to haemorrhage in FDA adverse event reports:
HAEMORRHAGE has been reported as an adverse event in 94 FDA reports for AMINOCAPROIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAEMORRHAGE accounts for approximately 7.0% of all adverse event reports for AMINOCAPROIC ACID, making it one of the most commonly reported side effect.
If you experience haemorrhage while taking AMINOCAPROIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.